Article
Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?
Expert review of anti-infective therapy - 1 Jan 2016
Nafisi Shirin, Roy Sabyasachi, Gish Robert, Manch Richard, Kohli Anita
Abstract excerpt
UNLABELLED: This review summarizes published data on sofosbuvir-based regimens for patients infected with HCV GT1 with a focus on evaluating the optimal and possible durations of treatment. METHODS: PubMed and conference abstract books published between 2011-2015 were searched. RESULTS: HCV treatment has decreased from 24 week regimens to studies done as short as 4 weeks. History of prior treatment or cirrhosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.